Browsing by Author : 유창훈
Showing results 1 to 31 of 31
- 1 Article Adjuvant Chemotherapy for Resected Ampulla of Vater Carcinoma: Retrospective Analysis of 646 Patients 권재우 ; 김규표 ; 김명환 ; et al 2021
-
2
dissertation
BRCA2 돌연변이 췌장암에서 PARP 억제로 인한 Oxaliplatin의 항종양효과 규명 연구
김단비
2022
- 3 Article Capecitabine plus temozolomide in patients with grade 3 unresectable or metastatic gastroenteropancreatic neuroendocrine neoplasms with Ki-67 index < 55%: single-arm phase II study 김규표 ; 김용일 ; 류백렬 ; et al 2021
- 4 Article Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy 김규표 ; 류백렬 ; 방경혜 ; et al 2021
- 5 Article Clinical outcomes of systemic therapy in patients with unresectable or metastatic combined hepatocellular-cholangiocarcinoma 강효정 ; 김강모 ; 김규표 ; et al 2021
- 6 Article Clinical Outcomes with Multikinase Inhibitors after Progression on First-Line Atezolizumab plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Multicenter Retrospective Study 김강모 ; 김좌훈 ; 류백렬 ; et al 2021
- 7 Article CT-determined resectability of borderline resectable and unresectable pancreatic adenocarcinoma following FOLFIRINOX therapy 장종건 ; 변재호 ; 강지훈 ; et al 2021
- 8 Article Current Status and Future Perspectives of Perioperative Therapy for Resectable Biliary Tract Cancer: A Multidisciplinary Review 김규표 ; 류백렬 ; 박준오 ; et al 2021
- 9 Article Evolving Treatment of Advanced Hepatocellular Carcinoma in the Asia-Pacific Region: A Review and Multidisciplinary Expert Opinion 유창훈 ; Bruce Wang ; Dee Lee ; et al 2021
- 10 Article Expression of HER2 and Mismatch Repair Proteins in Surgically Resected Gallbladder Adenocarcinoma 김규표 ; 김성주 ; 성유나 ; et al 2021
- 11 Article Feasibility of HER2-Targeted Therapy in Advanced Biliary Tract Cancer: A Prospective Pilot Study of Trastuzumab Biosimilar in Combination with Gemcitabine Plus Cisplatin 김규표 ; 류백렬 ; 박도현 ; et al 2021
- 12 Article Identification of Regorafenib Prognostic Index (REP Index) via Recursive Partitioning Analysis in Patients with Advanced Hepatocellular Carcinoma Receiving Systemic Treatment: A Real-World Multi-Institutional Experience 김형돈 ; 류백렬 ; 방영학 ; et al 2021
- 13 Article Implication of CD69(+)CD103(+) tissue-resident-like CD8(+) T cells as a potential immunotherapeutic target for cholangiocarcinoma 김상엽 ; 김형돈 ; 박성열 ; et al 2021
- 14 Article Kinetics of the neutrophil-lymphocyte ratio during PD-1 inhibition as a prognostic factor in advanced hepatocellular carcinoma 김강모 ; 김지윤 ; 류백렬 ; et al 2021
- 15 Article Lenvatinib versus sorafenib in first-line treatment of unresectable hepatocellular carcinoma: An inverse probability of treatment weighting analysis 김형돈 ; 방영학 ; 유창훈 ; et al 2021
- 16 Article Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliary tract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study 강명주 ; 강병욱 ; 김경원 ; et al 2021
- 17 Article Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the second-line chemotherapy for patients with metastatic pancreatic cancer: a multicenter retrospective study of the Korean Cancer Study Group (KCSG) 강명주 ; 강버들 ; 강정훈 ; et al 2021
- 18 Article Metabolic activity by FDG-PET/CT after neoadjuvant chemotherapy in borderline resectable and locally advanced pancreatic cancer and association with survival 권재우 ; 김규표 ; 김송철 ; et al 2021
- 19 Article Multiparametric MRI for prediction of treatment response to neoadjuvant FOLFIRINOX therapy in borderline resectable or locally advanced pancreatic cancer 강지훈 ; 김규표 ; 김송철 ; et al 2021
- 20 Article Prediction of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma using imaging features of gadoxetic acid-enhanced magnetic resonance imaging 변지은 ; 유창훈 ; 김소연 ; et al 2021
- 21 Article Prognostic Value of 18F-FDG PET in Neuroendocrine Neoplasm 김태형 ; 류백렬 ; 류진숙 ; et al 2021
- 22 Article Radiation therapy for recurrent extrahepatic bile duct cancer 고민지 ; 김규표 ; 김종훈 ; et al 2021
- 23 Article Real-world data analysis of patients with cancer of unknown primary 강소라 ; 김규표 ; 김정은 ; et al 2021
- 24 Article Regorafenib versus cabozantinb as second-line treatment after sorafenib for unresectable hepatocellular carcinoma: matching-adjusted indirect comparison analysis 김형돈 ; 류백렬 ; 방영학 ; et al 2021
- 25 Article Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with regorafenib 김형돈 ; 류백렬 ; 방영학 ; et al 2021
- 26 Article Sequential Treatment of Sorafenib-Regorafenib Versus Sorafenib-Physician's Choice: A Propensity Score-Matched Analysis 김형돈 ; 류백렬 ; 박숙련 ; et al 2021
- 27 Article Spatial Distribution and Prognostic Implications of Tumor-Infiltrating FoxP3(-) CD4(+) T Cells in Biliary Tract Cancer 김규표 ; 김기훈 ; 김단비 ; et al 2021
- 28 Article Systemic Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors in Korea: Literature Review and Expert Opinion 김승태 ; 류백렬 ; 배우균 ; et al 2021
- 29 Article Value of 18F-FDG PET in Neuroendocrine Neoplasm: A Systematic Review and Meta-analysis 김태형 ; 류백렬 ; 류진숙 ; et al 2021
-
30
Dissertation
다중형광염색 및 RNA 분석을 이용한 위장관 기질 종양의 포괄적 면역 프로파일링 분석: 티로신키나아제 치료의 종양 면역 미세 환경의 영향
유창훈
2018
-
31
dissertation
선행항암화학요법 modified FOLFIRINOX 후 수술을 받은 췌관선암 환자에서 보조항암화학요법 시행의 임상적 필요성과 예후
이소흔
2022
1